Use in type 1 diabetes The ADJUNCT ONE trial (Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes), 55 the ADJUNCT TWO trial, 56 and a large meta-analysis 57 found reductions in hemoglobin A1c, body weight, and total daily dose of insulin, but also highlighted an increase in hyperglycemia with ketosis in patients with type 1 diabetes mellitus receiving liraglutide or exenatide in combination with insulin
Li D, Li Y
doi: 10.1111/hel.12796 39 GrasbergerHEl-ZaatariMDangDTMerchantJL
Sipping water throughout the day rather than consuming large amounts with meals is preferred, as large fluid volumes during meals can worsen gastric distension
There are GLP-1 receptors in blood vessels and on the heart, including, Coviello said, on the sinoatrial nodes that controls the heart rate
The potential systemic side effects, like nausea or digestive changes, are the same as they are caused by the medication itself